Tag: cancer

biotech

FDA clears allogeneic CAR-T recurrent glioblastoma therapy for phase II trial

biotech

Base to Base biotech podcast 40: Anchored immunotherapy, and healing the skin

biotech

First precision therapy prostate cancer drug approved

biotech

Breast cancer vaccine endpoints met with 74% immune response

biotech

Pan Cancer T raises €10m for first-in-human trial of novel TCR-T cell therapy for triple-negative breast cancer

biotech

Vivacta Bio shows promising results for in vivo CAR-T therapy in non-Hodgkin’s lymphoma

biotech

CRS programme to feature Poolbeg Pharma trial

biotech

Potent and selective antitumour activity in acute myeloid leukaemia study